-
). The fellow will work under the mentorship of Dr. Amy Knopf, an established nurse scientist whose research focuses on health equity, health disparities, social determinants of health, bioethics, and clinical
-
the context of clinical trials. Clinical work (50%) will involve serving as a research clinician performing assessments on an NIH-funded randomized controlled trial treating adolescents with binge eating
-
Alzheimer’s disease pathogenesis and neurodegeneration. Ongoing projects investigate microglial signaling pathways, neuroimmune interactions, genetic risk factors, and therapeutic targets using state-of-the-art
-
techniques that include, but are not limited to, cell culture, western blotting, PCR, gene knockdown and overexpression, immunofluorescence, and immunohistochemistry. Laboratory work will involve animal
-
through the collaborative development, production, and characterization of AAV vectors for experimental applications. The successful candidate will work as an integral member of a team focused on designing
-
. The candidate must have expertise in the synthesis of colloidal inorganic nanocrystals: air-free synthesis and work-up (including Schlenk line and glovebox proficiency), powder X-ray diffraction, absorption
-
discovery to identify children at risk for developing kidney disease and to guide personalized treatment strategies. By leveraging advanced technologies in genomics, proteomics, and metabolomics, our goal is
-
biomedical sciences. Previous research experience in genetics and/or proteomics is highly desirable, but not required. Ability to work with animal models is required. Salary is compatible with NIH pay schedule